Newsroom
Inkocell Therapeutics secures CHF 150,000 from Venture Kick to advance next-generation Natural Killer (NK) cell therapies
08.09.2025
EPFL spin-off Inkocell Therapeutics, a Swiss biotech startup developing next-generation cell therapies, has secured CHF 150,000 fr ... more
ETH spin-off OBaris acquired by Johnson & Johnson
03.09.2025
Johnson & Johnson has acquired OBaris, a Swiss Biotech spin-off developing a novel drug delivery platform. With its OctoPatch® tec ... more
CompPair and SBB partner to increase durability and sustainability of InterCity trains
02.09.2025
Swiss Federal Railways (SBB) and CompPair Technologies are joining forces to enhance the performance and sustainability of the ICN ... more
Newsletter Archive
Kickers among finalists??
Kickers on Top of the Charts ?
Kickers Reaching Orbit?????
Building Global Leaders ??
Press releases
Press review
Versive erhält CHF 150'000 von Venture Kick
Media contacts
For media enquiries, please email our communications team. If you have a general question about Venture Kick please visit our about us page.
Learn more about Venture Kick or download the latest annual report for detailed information.
